Trial Details
TERMINATEDBasic Information
| Clinical ID | c3396 |
|---|---|
| Identifier | NCT02120027 |
| Trial Title | 52-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Irritable Bowel Syndrome With Diarrhea |
| Interventions | DRUG: Ibodutant 10 mg|DRUG: Placebo |
Participant Information
| Sponsor | Menarini Group |
|---|---|
| City | Chandler |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | FEMALE |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2014-02 |
|---|---|
| Primary Completion Date | 2015-11 |
| Completion Date | 2015-11 |